Vermont's 2027 Rate Cut Comes With a Reference-Pricing Order

Reference-based pricing replaces a negotiated hospital rate with an administered one: instead of a health plan and a hospital agreeing bilaterally on a network contract, the payer caps reimbursement at a fixed multiple of the Medicare fee schedule, the benchmark commercial insurers price at roughly 254% of Medicare on average nationally (RAND, May 2024). Vermont's Green Mountain Care Board (GMCB) put a hospital-fiscal-year-2027 deadline on adopting exactly that mechanism, issuing a Supplemental Order on August 18, 2026 the same day it finalized 2027 individual and small-group rates that cut Blue Cross Blue Shield of Vermont's (BCBSVT) filed individual increase to 2.2% from a requested 6.5% (GMCB, August 18, 2026).

Every outlet that covered the decision led with the rate numbers, and they are genuinely modest by 2027 standards: a median proposed increase of 15% across the 276 insurers with public 2027 marketplace filings nationally, against Vermont's own already-low statewide average of 6.5% requested before the board cut it further (Peterson-KFF Health System Tracker, August 2026). But a rate cut is a one-year event. The reference-based-pricing order is a multi-year commitment that resets the unit-cost assumption sitting underneath every future BCBSVT and MVP filing, and it is the piece of the August 18 decision an actuary building a 2028 trend assumption in Vermont needs to understand now, not after the rulemaking is finished.

The Rate Numbers, and the Gap Between Filed and Approved

The board's four approved rate changes each came in below what the carriers filed, by a margin GMCB itself sized at 2.9 to 4.3 percentage points depending on carrier and market segment (Vermont Business Magazine, August 19, 2026). BCBSVT's individual filing requested 6.5% and was approved at 2.2%, a 4.3-point cut; its small-group filing requested 4.5% and was approved at 1.2%, a 3.3-point cut. MVP's individual filing requested 7.8% and was approved at 3.9%, a 3.9-point cut; its small-group filing requested 9.1% and was approved at 6.2%, the smallest cut of the four at 2.9 points. Combined, the board's decisions are expected to reduce 2027 premiums for the roughly 67,000 Vermonters covered across the two carriers' individual and small-group books by about $24 million relative to what was filed (GMCB, August 18, 2026).

GMCB Chair Owen Foster framed the outcome against the national backdrop rather than against the carriers' own requests: "Through strong legislative efforts and GMCB's work to control costs, Vermont had the second-lowest increase in ACA Marketplace benchmark premiums in the nation for 2026" (Times Argus, August 18, 2026). That framing matters for how the cut should be read. Nationally, insurers are pricing a median 10% medical trend into 2027 filings, up from an 8% average in recent years, and layering an estimated 4 to 6 additional points onto rates for a sicker risk pool left behind after enhanced premium tax credits expired at the end of 2025 (Peterson-KFF Health System Tracker, August 2026). Vermont's carriers filed well under that national trend picture before the board cut them further, which is consistent with a smaller, more heavily regulated risk pool rather than with carriers padding requests to be negotiated down, the pattern that shows up in states like New York, where DFS cut individual-market requests nearly in half.

What Reference-Based Pricing Replaces in the Unit-Cost Line

A conventional QHP rate filing builds its unit-cost assumption from negotiated hospital contracts: a base allowed amount per service, escalated by whatever percentage increase the carrier and hospital system agreed to in their most recent contract renewal, then trended forward for utilization and mix shift. Reference-based pricing under Act 68 replaces the negotiated escalator with an administered one. The statute directs GMCB to establish, no later than hospital fiscal year 2027, maximum reimbursement amounts for hospital services set as "a percentage of the Medicare reimbursement for the same or a similar item or service, or on another benchmark, as appropriate" (GMCB Supplemental Order, August 18, 2026). Once that benchmark is in place, a carrier's unit-cost trend for the affected services stops tracking whatever the hospital system negotiated in its last contract cycle and starts tracking the Medicare fee schedule's annual update factor, plus whatever multiple GMCB sets and however often the board chooses to revisit it.

Vermont is not writing on a blank slate here. Montana's state employee health plan adopted reference-based pricing in 2016, settling on 234% of Medicare for all hospital inpatient and outpatient services and generating an estimated $47.8 million in savings from fiscal years 2017 through 2019; the state's newer arrangement with Blue Cross Blue Shield caps reimbursement at 200% of Medicare, stepping down to 180% by 2026 (National Academy for State Health Policy, 2026). Set against RAND's national finding that commercial payers averaged 254% of Medicare in 2022, with outpatient facility charges running even higher at 279% (RAND, May 2024), Montana's 180%-to-234% band gives Vermont regulators a concrete precedent for where a benchmark multiple could land relative to the roughly 250%-plus ratio Vermont hospitals likely command today under negotiated contracts. Act 68's own scope is broader than Montana's, though: it applies statewide across the entire commercial market rather than to a single employer plan, which is the detail Health Affairs Forefront has flagged as making Vermont's version the most expansive reference-based-pricing law adopted by any state to date. GMCB's rulemaking through 2027 is expected to set the specific multiple and which service categories it covers, with a public meeting on the reference-based-pricing docket scheduled for August 26, 2026, eight days after the Supplemental Order issued (Times Argus, August 18, 2026).

The Actuarial Mechanics of a Regulator-Directed Trend Cut

Cutting a filed loss-ratio or trend pick by 2.9 to 4.3 points is not simply arithmetic on the top-line rate; it is a statement about which of the carrier's underlying assumptions the regulator does not accept. In BCBSVT's case, the board went further than adjusting the top-line number: it required BCBSVT's rate filing to use hospital cost assumptions that reflect the board's own FY27 Hospital Budget Guidance and recent hospital-budget enforcement actions, rather than the assumptions BCBSVT built from its own contract negotiations (Vermont Business Magazine, August 19, 2026). That is a materially different kind of intervention than a state simply disallowing a carrier's requested margin. It substitutes the regulator's hospital-cost trend for the carrier's own, which is precisely the substitution reference-based pricing formalizes on a permanent basis once the Medicare-multiple benchmark takes effect. Read together, the FY2027 hospital-budget-guidance directive and the reference-based-pricing Supplemental Order are the same actuarial move at two different time horizons: one overrides this year's hospital-cost trend pick, the other overrides every future one.

For a pricing actuary building the next Vermont filing, that has a direct consequence for how much confidence to place in a trend assumption built from historical contract data. A book with even a partial share of claims reimbursed at an administered Medicare multiple no longer has a single trend rate; it has a blended rate across reference-priced services (tracking CMS's annual fee-schedule update, typically low single digits) and negotiated services still tracking hospital contract escalators, which have been running well ahead of the 10% national medical-trend median that already worries carriers in 2027 filings elsewhere (Peterson-KFF Health System Tracker, August 2026). Getting the mix wrong, overestimating how much of the book migrates to the reference price in year one of implementation, or underestimating how quickly hospitals push volume or acuity toward services the benchmark does not yet cover, is the specific mispricing risk this transition introduces, and it is the kind of risk a rate filing built entirely on trended historical claims cannot capture until GMCB's rulemaking specifies the multiple and its scope.

Balance Billing and the Reserve for Disputed Claims

Reference-based pricing's most-cited failure mode outside Vermont is balance billing: when a hospital does not accept the administered price as payment in full, it can bill the enrollee for the difference between its charge and the reference price, an outcome that looks nothing like a standard in-network claim from the member's perspective. Montana avoided this largely because its state employee plan is a single, concentrated purchaser with leverage to negotiate hospitals into the arrangement rather than impose it unilaterally; a statewide commercial mandate under Act 68 does not have that same negotiating dynamic built in, which is the practical reason GMCB's implementation timeline runs through a multi-year rulemaking rather than a single order. Vermont's version pairs the reference-pricing order with a second directive requiring the carriers to examine what they pay to out-of-state hospitals, an explicit acknowledgment that a Vermont-only benchmark does nothing to protect enrollees who cross into New Hampshire, New York, or Massachusetts for care outside the reference-price system entirely (Vermont Business Magazine, August 19, 2026).

For a carrier's reserving actuary, that dynamic has a direct claims-liability consequence. Disputed balance-billing claims, where a hospital disputes the reference price and a member disputes the resulting bill, do not resolve at the speed of a normal adjudicated claim; they sit in appeals and negotiation, sometimes for months, before final payment amounts are known. A reserve for disputed and unresolved balance-billing claims is a new line item a Vermont carrier's claims-liability estimate has not historically needed to carry at any real scale, and its size will depend entirely on how many hospitals decline to accept the reference price as payment in full once GMCB sets it, a fact pattern that will not be observable until implementation is well underway. Carriers moving into reference-based pricing elsewhere have generally needed one to two years of claims experience before that reserve component stabilizes into a predictable percentage of paid claims, which is a longer runway than the FY2027 statutory deadline gives Vermont's carriers before the first reference prices take effect.

A Capital Position That Just Turned the Corner

The margin-compression question the rate cut raises is sharper for BCBSVT than for MVP because of where BCBSVT's balance sheet stood entering this decision. Its risk-based capital ratio closed 2024 at 214%, the lowest in decades against a company target range of 500% to 700% that had held for over a decade, driven by medical utilization and unit costs running ahead of priced trend (VTDigger, May 2025). AM Best downgraded BCBSVT's financial strength rating twice in 2024, first to B (Fair) in August and then to C++ (Marginal) in December, before removing the group from under-review status in mid-2025 (AM Best via BusinessWire, December 2024). On July 23, 2026, less than a month before this rate decision, AM Best revised BCBSVT's outlook to positive, citing continuing improvement in operating performance "supported by more-favorable regulatory rate outcomes, which enhanced pricing adequacy and contributed to the strengthening of the group's capital position" (AM Best via BusinessWire, July 2026).

That timeline puts the August 18 decision in tension with the rationale AM Best gave for the positive outlook four weeks earlier. A rating agency crediting "more-favorable regulatory rate outcomes" for a capital recovery, followed a month later by the same regulator cutting the carrier's next filed rate by 4.3 points on the individual line, is not automatically a reversal; BCBSVT's approved 2.2% is still positive, not a rate decrease, and the board's public rationale ties the smaller increase to controlling hospital costs rather than to insurer margin. But a capital position rebuilt substantially on rate adequacy is more exposed to a regulator cutting the next filing than one rebuilt on underwriting improvement the carrier controls directly, and BCBSVT is carrying that exposure into a multi-year reference-pricing transition whose unit-cost impact on its own book will not be known until GMCB sets the benchmark multiple.

A Different Kind of Rate Cut Than New York's

The comparison to New York's Department of Financial Services is useful precisely because the two states' regulators arrived at similarly aggressive cuts through different mechanisms. DFS cut insurers' 2026 individual-market requests by 47.4% and small-group requests by 45.8%, saving policyholders an estimated $959 million, by disallowing components of the carriers' own trend and margin assumptions within the existing prior-approval framework (actuary.info, NY DFS 2026 rate review analysis). That is a cut to the number. Vermont's board cut the number too, by a smaller relative margin, but paired it with an order that changes the methodology the next filing will be built on. New York's carriers go back into their 2027 filing process using the same negotiated-contract framework DFS just cut against; Vermont's carriers go into their 2028 filing process using a partially administered unit-cost structure that did not exist when they built their 2027 numbers.

That distinction is the reason a single-digit approved rate is the less interesting number in this decision for anyone modeling Vermont's health-insurance market past 2027. A rate cut compresses margin for one plan year and gets re-litigated in the next filing on largely the same assumptions. A reference-price benchmark, once GMCB sets the multiple, changes what a unit-cost assumption is built from for as long as the benchmark stays in place, in the same way Vermont's separately-legislated hospital global-budget mandate, phasing in by 2030, is already reshaping the cost side of the ledger carriers price against (Act 68 of 2025, Vermont General Assembly). The rate filings that will show the reference-price effect are the ones GMCB has not yet reviewed.

Sizing the Open Questions Into 2027 and 2028

Three unresolved parameters determine how large the eventual unit-cost effect will be. The first is the multiple itself: a benchmark set near Montana's newer 180%-to-200% band would represent a meaningfully larger cut to Vermont hospital reimbursement than one set closer to the 234% Montana originally used, given that RAND's national data puts the pre-reform commercial average around 254% of Medicare. The second is scope: whether the benchmark applies to all hospital services immediately or phases in by service category, which determines how much of a carrier's claims cost is even exposed to the new trend in the first implementation year. The third is timing relative to global budgets: Act 68's hospital global-budget mandate phases in on a separate track through 2030, and a reference price set against a hospital's budgeted revenue base interacts with that budget in ways GMCB's February 2026 legislative update to Act 68 acknowledged it is still working through (GMCB Act 68 Update, February 2026). None of the three is resolved by the August 18 order; all three are scheduled for GMCB's rulemaking process through 2027, which is the calendar a Vermont pricing actuary should be tracking more closely than the 2.2% headline number that made the news.